ArriVent BioPharma (AVBP) Change in Accured Expenses (2023 - 2026)
ArriVent BioPharma (AVBP) reported Change in Accured Expenses of $9.14 million for Q2 2026, up 30.1% from $7.03 million a year earlier.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, ArriVent BioPharma's Change in Accured Expenses came in at $9.83 million, up 33.9% year-over-year; for FY2025, it was $6.67 million, up 4.5% from FY2024.
- By year, Change in Accured Expenses came in at $6.38 million in FY2024 (+309.8%) and $1.56 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Change in Accured Expenses in data going back to Q1 2023.
- Year over year, Change in Accured Expenses gained in four of the last five quarters, with growth averaging 58.5%.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$3.83 million (Q1 2026), $4.43 million (Q4 2025) and $91,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | 9.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.14 Mn |
| Mar 31, 2026 | -3.83 Mn |
| Dec 31, 2025 | 4.43 Mn |
| Sep 30, 2025 | 91,000.00 |
| Jun 30, 2025 | 7.03 Mn |
| Mar 31, 2025 | -4.88 Mn |
| Dec 31, 2024 | 2.97 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | -963,000.00 |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Jun 30, 2023 | 3.18 Mn |
| Mar 31, 2023 | -2.04 Mn |
API Access
ArriVent BioPharma Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();